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 Identifying chemicals that can promote the regeneration of liver tissue would be 
important for curing various liver diseases and ameliorating liver damage in humans.  
Due to their transparency, Danio rerio (zebrafish) embryos are a useful tool for studying 
organ regeneration.  In order to study the regeneration of the liver using zebrafish, a 
method of destroying or ablating the embryo livers is necessary.  Currently the methods 
for destroying zebrafish livers to observe the regeneration fall under two categories, 
hepatectomy (surgical removal of liver tissue) or organ specific chemical ablation.  
Previous methods of specific organ ablation in zebrafish models use transgenic lines that 
are made to express a certain enzyme that can then convert a normally non-toxic 
chemical into a toxic form [1].  This method is difficult because of the requirement of 
special transgenic lines.   
Acetaminophen (APAP) is one of the most common over-the-counter pain 
medications in the world [2].  Although it is normally used to treat pain, overdoses have 
been found to cause hepatotoxicity and acute liver failure [3].  Based on this information, 
acetaminophen administered in water was explored as a possible easier method of 
directed liver ablation in zebrafish embryos.  Because acetaminophen damage causes 
acute liver failure, zebrafish liver ablation using this drug could be a model for studying 
acute liver failure, and testing possible antidotes/drugs to cure the disorder.  
A transgenic zebrafish line expressing a green fluorescent protein (GFP) in the 
liver was used to assess the damage and regeneration of the livers of tested embryos.  
Treating zebrafish embryos from 2-4dpf (days post fertilization) with various 
concentrations of acetaminophen, it was found that acetaminophen at certain 
concentrations can be used effectively to ablate embryo livers without killing them.   
This model was then used to destroy the livers of embryos used in a large-scale 
chemical screening of possible regeneration promoting chemicals.  Compounds were 
screened first from a Tim Tec compound library.  Because the cellular targets of each of 
the novel compounds in the Tim Tec library are not known, further screening using a 
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compound library targeting stem cell signaling pathways was performed in order to have 
a more controlled and directed screening.  The compounds from both libraries were tested 
at 50µM, but due to high mortality at this concentration, further screening of the Stem 
Cell plate was performed at 25µM in an attempt to reduce the toxicity of the compounds.  
Through treatment of the injured embryos from 4-5dpf, several candidates of liver 
regeneration promoters were found.  The chemicals from the stem cell library that were 
deemed promising were tested again at 50µM, 25µM, and 12.5µM to confirm their 
efficacy.  The wider range of concentrations revealed several chemicals as possible 
promoters of hepatic regeneration.  A trend was observed that many of the promising 
compounds affect the same signaling pathway in the stem cells.  This finding revealed 
some pathways that are promising to have strong effects on the proliferation and 
differentiation of hepatic stem cells following a chemical injury.  If further testing 
confirms the efficacy of the promising compounds, their ability to promote regeneration 
of hepatocytes could eventually lead to these compounds being formulated into drugs or 

















The regenerative property of the human liver has been common knowledge for 
thousands of years.  The concept of liver regeneration can be traced as far back as ancient 
Greek mythology.  In the legend of Prometheus, after defying the gods, the Titan 
Prometheus was sentenced to be bound to a rock where an eagle would eat his liver, 
which would grow back every morning, and create an eternal cycle of punishment. 
In reality, vertebrate livers do not regenerate based on the technical standards of 
regeneration.  True regeneration occurs through the development of a blastema at the 
injury site that is made up of undifferentiated cells.  The cells divide and differentiate and 
eventually the form and function of the tissue is restored [4].  Vertebrate livers regrow 
through a process called compensatory growth.  During this process, cells in the liver 
divide in order to replace the mass that was lost, however, while the general size and 
mass of the liver may be restored to normal, the new growth does not reform the lost 
structures and lobes exactly [4].   
Livers are comprised mainly of parenchymal cells known as hepatocytes.  The 
hepatocytes are the cells that are responsible for the main functions of the liver including 
protein storage, detoxification of substances, transformation of carbohydrates, and the 
synthesis of proteins, bile salts, cholesterol, and phospholipids.  When a mass of 
hepatocytes is removed through a hepatectomy, the remaining cells begin to divide to 
replenish the lost mass.  When hepatocytes are destroyed due to chemicals or toxins, the 
tissue is replaced through the replication and differentiation of hepatic progenitor/stem 
cells[4].   
Acute liver failure (ALF) is a relatively rare condition that is characterized by the 
rapid loss of hepatic function.  Excessive alcohol consumption, drug/toxin induced liver 
damage, various metabolic problems, and many different viral liver diseases, such as 
hepatitis, can cause ALF.  ALF can lead to cerebral edema, bleeding disorders, and 
hepatic encephalopathy.  These complications can quickly lead to coma and death in 
patients.   
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Currently, the only  method of effective therapy for ALF is liver transplantation.  
According the U.S. ALF study group, from 1998-2007 44% of patients with the disease 
were placed on a transplant list [5].  Of the 44% placed on the list, 25% received a 
transplant and had a survival rate of 70% over the next year.  Of the remaining patients, 
10% died on the waiting list, and 9% recovered spontaneously.  In total 30% of the 
patients in the study group died of the disease.  In 2011, the waitlist to receive a liver 
transplantation was over 16,000 patients long in the United States alone.  During this 
same year, only 39% of patients on the transplant waitlist received a transplant, and 15% 
of patients died waiting [6].  Although the survival rate of those who received the surgery 
was very high (89.5%), the small percentage of patients who received treatment makes 
transplantation ineffective as the primary method of treating the patients in need.  This 
represents a need for a more simple and effective method of treating acute liver failure.  
Acetaminophen is one of the most commonly used analgesics in the over-the-
counter drug market today.  It is the main ingredient in common brand name pain 
medicines like Tylenol.  Acetaminophen overdoses were the cause of 46% of the ALF 
cases between 1998 and 2007 among adults in the US [5].  Overdoses of acetaminophen 
alone or in combination with other drugs cause over 300 deaths annually [7].  
Acetaminophen is not only the most common drug induced cause of ALF, but also the 
most common cause in general.   
Ingested acetaminophen is converted into a toxic metabolite, N-acetyl p-
benzoquinone (NAPQI), by cytochrome p450 enzymes in the liver [3].  At recommended 
doses, NAPQI is inactivated by glutathione, but during an overdose, unconjugated 
NAPQI leads to dysfunction of critical liver cell proteins, oxidative stress, and 
mitochondrial damage.  These damages lead to necrosis of hepatocytes, which causes 
acute liver failure.   
Current research shows that other than transplantation, the only somewhat 
effective therapy for treating acetaminophen caused liver damage is N-Acetylcysteine 
(NAC).  NAC is normally administered to patients who seek help quickly after an 
acetaminophen overdose.  NAC has been shown to reduce mortality in acetaminophen 
overdose situations by 20-28%, but only has a window of efficacy within 12 hours of the 
ingestion of the acetaminophen [3].  Treatment of NAC after the effective window or 
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prolonged treatment has been shown to have a negative influence on the outcome and 
survivability of the patient.  The restricted time in which NAC can be used as an effective 
antidote for acetaminophen liver damage shows a necessity for the exploration of other 
chemicals or compounds, which might induce proliferation and regeneration after injury. 
The damage of acetaminophen on hepatocytes is chemical, and therefore the 
regeneration of the liver occurs through the replication and differentiation of hepatic 
progenitor/stem cells.  By performing a wide chemical screening of novel compounds, 
especially ones known to target various cell-signaling pathways in liver stem cells, this 
project could identify potential compounds that can be used to promote the regeneration 
of the liver after a chemical injury.  Discovering promising novel compounds during this 
screening could also help identify which cell signaling pathways may be critical in 
promoting the growth, replication, and differentiation of hepatic stem/progenitor cells to 
create new tissue.  Further studies confirming the efficacy of any promising compounds 
could lead to the development of more successful and consistent methods of treating 
patients suffering from acute liver failure, or acetaminophen overdose, without the 













MATERIALS AND METHODS 
Materials 
The fish embryos were obtained from an in-cross of transgenic zebrafish line 
“GFP”.  This transgenic line was helpful to the experiment because these fish express a 
green fluorescent protein in the cytosol of their hepatocytes.  This fluorescence allows for 
the visualization liver size in the developing embryos.  In order to keep the embryos 
transparent for the period of the experiment, their water was treated with 1M 1-phenyl 2-
thiourea (PTU).  PTU prevents melanogenesis in the embryos by blocking all of the 
tyrosine-dependent steps in the pathway [8].  Acetaminophen was used to ablate the 
livers of the test embryos.  Chemical screening was performed using novel compounds 
from three plates from Tim Tec library (88 compounds each for 264 total), as well as a 75 
compound plate of stem cell targeting novel compounds. 
 
Obtaining Embryos  
Several mating tanks of GFP fish were assembled.  These tanks contained one 
male and one female fish and were left overnight for fertilization to occur.  The next day 
(Day 0) the embryos were harvested into petri dishes with about 80 embryos per dish.  
The egg water was replaced with 20ml of new egg water and the embryos were placed in 
a 24
o
 incubator overnight.  On Day 1, the egg water was removed and replaced with 19ml 
of egg water and 1ml of 1xPTU solution per plate in order to prevent pigmentation. 
 
Acetaminophen Dose Experiment  
On Day 2, the dishes were split into four groups in a six well plate, one control 
and three experimental.  Each group contained 25 embryos.  The control embryos were 
left in only egg water.  The other three had their egg water treated with acetaminophen to 
make 5µM, 10µM, or 25µM solutions.  The embryos were left in the incubator until Day 
4.  On Day 4, the embryos were removed and split up into a glass 9 well plate.  They then 
were observed using a fluorescent microscope, and images of the fluorescent livers were 
recorded for each test group.  All pictures were taken from the ventral side of the fish, at 
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the same magnification (100x).  The comparative size of the livers in each group was 




The embryos underwent the same procedure as above for the 10mM 
acetaminophen treatment up to day 4.  On day 4, the test embryos were washed to stop 
ablation and placed in clean egg water.  Images were taken of the control and ablated 
embryos for the pre-treatment size of the livers.  Embryos were then placed in a 96 well 
plate with 3-5 embryos in each plate along with 199µl of egg water.  Wells in column 1 
are controls with 1-A through 1-D being unablated controls and 1-E through 1-H being 
ablated embryos that will not be treated with chemicals.  The embryos in columns 2-12 
then had 50µM (1µl diluted in 199µl egg water) of the chemical in the corresponding 
well of the novel compound 96 well plates added to them.  The 96 well plates were then 
wrapped in foil to block out the sun and placed in an incubator overnight.  On day 5, 
images of the livers of all of the surviving embryos were obtained.  Images were not 
recorded for wells in which the embryos died or did not show visibly larger livers than 
the acetaminophen control wells.   
 
Stem Cell- 
The same general procedure was followed as performed in the Tim Tec screening 
except 4-8 embryos were placed in wells of 24 well plates along with 400µl egg water 
until enough were filled to accommodate all 75 compounds, unablated controls, and 
ablated controls.  Originally, the stem cell compounds were screened at 50µM, but after 
observing high mortality among the embryos, a second trial using 25µM was performed.  
The promising compounds from these screening were tested a second time at using 10 
embryos tested for each promising compound at 50µM, 25µM, and 12.5µM.  Images 












Figure 1. Acetaminophen Dose Experiment A) Control at 4dpf,   B) 5mM test at 
4dpf,   C) 10mM test at 4dpf 
 
Summary:  As shown in Figure 1.A the control fish developed large sized livers.  Figure 
1.B shows that the fish treated with 5mM acetaminophen exhibited a notable decrease in 
liver size.  The zebrafish exposed to 10mM acetaminophen showed a much more 
significant decrease in the size of their livers (Figure 1.C).  At day 4 the survival rate of 
the embryos in each group was 25/25 control, 25/25 5mM APAP, 21/25 10mM APAP, 
















Figure 2.  A) Control embryos at 4dpf B) APAP treated control embryos at 4dpf.  C) 






















 1 2 3 4 5 6 7 8 9 10 11 12 
A N N N X X X X X X X X X 
B N X X X X X X X X X X X 
C N X X X X X X X X X X X 
D N X X X N X X X X X X X 
E X X X P X X X X X X X X 
F X X X X X X X X X X X X 
G X X X X P X X X X X X X 
H X X X X N X X X X X N X 
Table 1) Chemical Plate 1.  X=Died, N=No regeneration, P=Promising 
 
  










 1 2 3 4 5 6 7 8 9 10 11 12 
A X X X N X X X X X X N X 
B X X X X X X X X X X X X 
C X X X X X X X X X X X X 
D X X X X X X X X X P X X 
E N X X X X X X X X X N X 
F X X X X X X X X X X X X 
G N X X X X X X X P X X X 
H X X X X X X X X P X X X 









































 1 2 3 4 5 6 7 8 9 10 11 12 
A N X N X X X X X X X X X 
B N  N N X X X X X X X N X 
C N X X X X P X X X X X X 
D N  X N X X X X X X X X X 
E X X X X X X X X X X N X 
F N  X X X X X X X X X X X 
G X X X X P X X X X X X X 
H N  X X X X X N X N X X X 
Table 3) Chemical Plate 3.  X=Died, N=No regeneration,  P=Promising 
 
  







Summary:  Three plates of novel compounds from the Tim Tec library have been 
screened.  As shown in Figure 2, the embryos that were treated with 10mM APAP from 
2-4dpf showed significantly smaller livers on day 4 and 5 compared to the controls.  The 
remaining figures (3-5) show that, of the chemicals screened (264), there are seven that 
elicited significant regeneration compared to the APAP treated controls.  As seen in 
Table 1, 2, and 3 the majority of the chemicals tested in each plate caused the embryos to 
die.  Many of the embryos that survived the chemical treatment did not show 

































Stem Cell Chemical Screening 
 
 
Day 5, 50µM Chemical Trial: 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A X X P X X X X X X X X E 
B P   X X X X X X X X X P E 
C X X X P X X X X X X X E 
D X   X P X X N X X X P X E 
E X P X X X X X X X X X E 
F N  X X X X X X X X N  N  E 
G X X X X X X X X X E E  E 
H E E E E E E E E E E E E 
Table 4) Stem Cell 50µM.  X=Died, N=No regeneration, P=Promising, E=Empty 
Layout based on Stem Cell compound plate 
 
Summary: Table 4 shows that the initial 50µM screening of the stem cell library 










Day 5, 25µM Chemical Trial: 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A X N N X P N N X X X X E 
B N   X P X X N X X N X X E 
C N X N P X X X N N X N E 
D X   N N X N X N X P N X E 
E X X N X X X N X X X N E 
F X   X N P X X X X X X   P   E 
G N X X X X X N X X E E  E 
H E E E E E E E E E E E E 
Table 5) Stem Cell 25µM.  X=Died, N=No regeneration, P=Promising, E=Empty 
Layout based on Stem Cell compound plate 
 
Summary:  Table 5 shows that at 25µM there are still some compounds that exhibited 
higher regeneration of the liver compared to the control, and that fewer chemicals killed 













Promising Compound Rescreen: 
 
Mortality 
Compound 50µM 25µM 12.5µM Target 
1-B 1 5 2 “A” 
2-E 0 1 X “B” 
3-A 8 X X “B” 
3-B 1 1 0 “C” 
3-D 0 2 0 “D” 
4-C 0 0 1 “D” 
4-E 0 1 2 “B” 
4-F 1 1 5 “E” 
5-A 5 0 2 “C” 
9-D 0 2 0 “D” 
10-D 0 0 X “F” 
11-B 0 0 X “F” 
11-F 10 10 10 “G” 
Table 6) Dead embryos from each well of the rescreen (10 embryos per well) and the 
cell-signaling pathway targeted by the compounds tested.  X  represents 




Compound 50µM 25µM 12.5µM Target 
1-B 0 0 3 “A” 
2-E 3 0 X “B” 
3-A 0 X X “B” 
3-B 3 2 2 “C” 
3-D 1 1 2 “D” 
4-C 1 2 2 “D” 
4-E 1 2 0 “B” 
4-F 0 1 0 “E” 
5-A 3 2 0 “C” 
9-D 0 0 2 “D” 
10-D 6 4 X “F” 
11-B 3 0 X “F” 
11-F X X X “G” 
Table 7) The number of embryos in each treatment well that exhibited larger livers 
than the day 5 ablated control.  X marks treatments that were not performed or 








Figure 6.  Rescreen Controls A) Control embryos at 4dpf B) APAP treated control 
embryos at 4dpf.  C) Control embryos at 5dpf.  D) APAP treated control embryos at 

































Figure 7.  Rescreen Promising compounds A) 5-A 50µM, B) 5-A 12.5µM, C) 2-E 
50µM, D) 4-C 50µM, E) 4-C 25µM, F) 4-C 12.5µM, G) 5-A 50µM, H) 5-A 25µM, I) 







 As seen in Table 6, for most of the compounds, mortality did not seem to 
correlate with the concentration of the compound.  Some of the compounds (3-A and 11-
F) previously labelled promising killed all or almost all of the embryos in the rescreen.  
Table 7 shows that the some of the rescreened compounds did not cause very significant 
regrowth in most of their embryos and may not be very effective.  Compounds 3-B, 3-C, 
4-C, 4-E, 5-A, and 10-D seem to be able to promote regrowth at a wide range of 
concentrations.  2-E and 11-B seem to be most effective at high concentrations while, 1-B 
appears to be most effective at low concentrations.  Figure 7 shows the regeneration seen 
at different concentrations of one of the compounds that affected each of the five 
signaling pathways, which had compounds show promising regeneration.  Cell pathways 
“A”, “B”, “C”, “D”, and “F” were affected by one or more of the compounds that caused 


















 As seen from Figure 1, acetaminophen administered in the water of the zebrafish 
embryos is effective at destroying or retarding the growth of developing livers.  The 
concentration of acetaminophen is critical for the directed ablation.  At 5mM, the drug 
elicited a small decrease in the liver size of the developing embryos; however, at a 
concentration of 10mM the liver was drastically smaller.  This experiment shows that 
with the correct concentration, acetaminophen can be used as a method of ablating livers.   
 The 25mM test proves that the dose does need to be specific.  All of the embryos 
in this test were killed, which leads to the conclusion that either the concentration of 
acetaminophen that they were exposed to completely destroyed the liver, which would 
cause death, or that acetaminophen in high concentrations can have other adverse effects 
on the organs of the zebrafish that could cause death.  There were a few embryos that 
were killed by the 10mM acetaminophen, but the 84% survival rate was enough to 
consider 10mM the ideal concentration for the ablation model.  Essentially, the theory 
that acetaminophen’s hepatotoxicity in humans can be also expressed in zebrafish and 
used as a method of ablation in the liver of embryos is supported by this experiment.  
This method of liver ablation can be used as a simple and reasonable method to study the 





  Using the acetaminophen ablation model, 264 novel Tim Tec compounds were 
screened for their ability to promote regeneration of the zebrafish embryo livers from 4-
5dpf.  Of the 264 compounds tested, around 97% caused mortality or reduced the liver to 
an unobservable size.  This extremely high mortality rate could have been the product of 
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chance and not solely be caused by the chemicals.  Further screening of the same plates 
may be necessary to be sure that mortality was not a coincidence.  The high mortality 
may have also been caused by the liver damage in individual embryos being too severe, 
and possibly beyond repair.   
 Seven compounds were found that caused a visible significant regeneration of the 
liver tissue compared to ablated embryos that were not treated with any novel 
compounds.  These results make those seven compounds good candidates for further, 
more specific, tests to confirm their ability to promote liver regeneration.  The cellular 
target of the compounds in the Tim Tec library are unknown, so many further tests will 
be needed to perfect their application.  If further testing proves any of the seven 
compounds to be successful at promoting liver regeneration, the compound will have the 
potential to one day become a drug that could be used to treat humans.   
 
Stem Cell-  
 The screening of the stem cell library revealed a few compounds that may be 
promising promoters of liver regeneration.  The compounds shown in Figure 7 along with 
compounds 3-B, 3-C, and 11-C showed a noticeable level of increased regeneration 
compared to the ablated control embryos.  The promising compounds that effected cell 
pathways “C” and “D” were observed to be effective at 50µM, 25µM, and 12.5µM 
during the rescreening.  Compounds effecting pathways “A”, “B”, and “F” were also seen 
to be promising, but only at certain concentrations.  This leads to the assumption that 
some of the pathways affecting the promotion of proliferation and differentiation of 
hepatic stem cells are more sensitive to changes in the concentration of one of the factors 
involved.  Some compounds were more effective at only high concentrations, some at 
only low concentrations, and some were lethal at high concentrations, which could mean 
that the concentration of the compound for screening is very critical to the promotion of 
regeneration.  Many of the results of the rescreen were inconsistent with the two rounds 
of screening at only 50µM or 25µM.  Although some of the compounds seem to be 
promising promoters of hepatic regeneration, because of all of the inconsistencies, further 






 The toxicity of acetaminophen seen in humans is relatable to a zebrafish animal 
model.  Acetaminophen can be used at specific concentrations for simple, controlled, and 
safe ablation of the liver of developing zebrafish embryos.  The chemical screenings have 
identified some promising compounds to promote the regeneration of livers after an 
acetaminophen injury, but there is not enough consistency and repetitiveness to make 
concrete conclusions about any of them.  Further screening of the promising compounds 
is necessary to confirm their effectiveness and potentially identify those that can be used 
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